Resilience, scepticism, and mRNA: The story of Katalin Karikó

Katalin Karikó mRNA vaccines for COVID-19

The COVID-19 pandemic presented the world’s governments and health organisations with a vaccination challenge on a scale it had never experienced before. Messenger RNA (mRNA) vaccines were critical in the production and distribution of affordable vaccines across the globe. Katalin Karikó’s 40 years of research into mRNA was the cornerstone of what made this possible. In this interview, we find […]

Read More… from Resilience, scepticism, and mRNA: The story of Katalin Karikó

Pathbreaking method leads to optimised mRNA production

Dr Sekirnik and his team at Sartorius BIA Separations optimised a crucial step in the mRNA production process, resulting in higher yield at lower cost.

The COVID-19 pandemic placed mRNA at the centre of biopharmaceutical research, as mRNA is now being developed for cancer therapy, protein replacement therapy, and infectious diseases. That is why, worldwide, the need to produce mRNA on a large scale has increased dramatically. The currently used method is quite costly, limiting the scale-up of mRNA production. Dr Rok Sekirnik and colleagues […]

Read More… from Pathbreaking method leads to optimised mRNA production